The patient package insert and oral dispenser should be. On january, 2010, shionogi received the worlds first marketing and manufacturing approval for both single dose administration of 300 mg i. Peramivir is a neuraminidase inhibitor antiviral 1 2 5 6 pharmacologically related to other neuraminidase inhibitors e. It is supplied in clear glass vials, each containing 375 mg. Attachment questions and answers for hospitals and healthcare professionals regarding termination of the emergency use authorization for peramivir iv on june 21, 2010, the u. Food and drug administration fda issued an emergency use authorization eua for the use of peramivir based on. Highlights of prescribing information these highlights do. Peramivir trade name rapivab is an antiviral drug developed by biocryst pharmaceuticals for the treatment of influenza. Abelcet consists of amphotericin b complexed with two phospholipids in a 1. The prescribing information for peramivir warns of possible neuropsychiatric.
Peramivir is excreted unchanged by the kidneys after iv dosing, with renal clearance of unchanged parent drug accounting for. Peramivir rapivab national drug monograph march 2015. Find patient medical information for peramivir pf intravenous on webmd including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Guidance for use and dosing of peramivir in hospitalized. Document peramivir synthland limited intermediates.
Easy to read fda package insert, drug facts, dosage and administration, and adverse effects for rapivab peramivir. Food and drug administration fda notified the centers for disease control and prevention cdc that the emergency use authorization eua allowing. Fda approval of peramivir makes iv flu drug available cidrap. Peramivir iv is authorized only for the following patients who are admitted to a hospital and under the care or consultation of a licensed clinician skilled in the diagnosis and management of. Pdf influenza virus infection is a major cause of morbidity and mortality in children and adults. Peramivir can be administered intravenously, a route that is favorable for hospitalized, critically ill patients with influenza. Insert tip firmly into opening of the bottle adapter. Rapivab plus standard of care did not improve median time to clinical resolution compared with standard of care alone.
Peramivir is a neuraminidase inhibitor with activity against influenza a and b viruses. Many of these cases were reported during postmarketing and causality was difficult to assess. Peramivir is used to treat influenza in adults and children who are at least 2 years old, who have had flu symptoms for up to 2 days peramivir may also. Peramivir is currently the only fdaapproved antiinfluenza agent that can be given as an intravenous injection. Assessment of adverse events related to antiinfluenza. List of chemical intermediates, fine chemicals suppliedmanufactured by synthland limited for peramivir. Given that the drug costs much more than oral oseltamivir but has similar efficacy, its role in uncomplicated influenza will likely be very limited. Famotidine is a white to pale yellow crystalline compound that is freely soluble in glacial acetic acid, slightly soluble in methanol, very slightly soluble in water, and practically insoluble in ethanol. Other less common side effects also have been reported. Mar 06, 2017 the concurrent use of rapivab with laiv intranasal has not been evaluated. Your health care provider can give you more information about these drugs or you can check the food and drug administration fda website for specific information about antiviral drugs, including the manufacturers package insert. Crossresistance between zanamivir and oseltamivir or peramivir has been observed in neuraminidase inhibition assays and cell culture assays. The effect of neuraminidase inhibitors on household.
Consider benefits of breastfeeding and importance of peramivir to the woman. Fda approves the intravenous influenza drug peramivir. List of chemical intermediates, fine chemicals suppliedmanufactured by synthland limited for peramivir please wait. Pdf peramivir injection in the treatment of acute influenza. Because of the potential for interference between these two products, avoid use of rapivab within 2 weeks after or 48 hours before administration of laiv unless medically indicated. Biocrysts partner shionogi launches peramivir in japan under. Prior to use, the supplied tamiflu powder must be constituted with water by the pharmacist to produce the oral suspension. Peramivir has not been associated with serum enzyme elevations during therapy or with clinically apparent liver injury. Arava is contraindicated for use in pregnant women see contraindications 4. Rapivab injection is a clear, colorless sterile, isotonic solution.
Vistide is a sterile, hypertonic aqueous solution for intravenous infusion only. Peramivir is a neuraminidase inhibitor, acting as a transitionstate analogue inhibitor of influenza neuraminidase and thereby preventing new viruses from emerging from infected cells. Peramivir works by preventing an enzyme in the body from releasing virus from infected cells. Peramivir is used to treat influenza in adults and children who. Relenza in patients with and without underlying airways disease. Rapivab peramivir dosing, indications, interactions. Rapivab is indicated for the treatment of acute uncomplicated influenza in patients 2 years and older who have. Relenza should be discontinued in any patient who develops bronchospasm or decline in respiratory function. Relenza is indicated for prophylaxis of influenza in adults and pediatric patients aged 5 years and older. These highlights do not include all the information needed to use rapivab safely and effectively. These highlights do not include all the information needed to use tamiflu safely and effectively. Pull the plunger out slowly until the desired amount of medication is. Biocrysts partner shionogi launches peramivir in japan.
The na amino acid substitutions that have been shown to result in reduced susceptibility to zanamivir and either oseltamivir or peramivir are summarized in table 9. Teratogenicity and embryolethality occurred in animal reproduction studies with leflunomide at doses lower than the human exposure level see use in specific populations 8. Peramivir has activity against both influenza a and influenza b viruses as demonstrated by both in vivo and in vitro studies. Peramivir, a neuraminidase inhibitor, is an intravenous iv drug authorized for emergency use for the treatment of certain hospitalized patients with known or suspected 2009 h1n1 influenza. This medicinal product is subject to additional monitoring. Rare cases of serious skin reactions, including erythema multiforme, have been reported with. Guidance for use and dosing of peramivir in hospitalized adults. The aes of peramivir were a high mortality rate, the development of acute respiratory distress syndrome 7%, and renal failure 5% in the faers system 30. Secondary infection patients were household members who were diagnosed with the same influenza typesubtype as the index patient between 24 hours and 7 days after the onset of symptoms in the index patient figure 1, similar to the time frame used in. On october 23, 2009, biocryst announced that the u. This is the preferred formulation 6 mg per ml for patients who cannot swallow capsules. Tamiflu oseltamivir phosphate capsules and oral solution. Cidofovir is a white crystalline powder with an aqueous solubility of.
Peramivir is an inhibitor of the influenza neuraminidase enzyme and is used as therapy of acute symptomatic influenza a and b. Severe allergic reactions have included anaphylaxis, erythema multiforme and stevensjohnson syndrome see warnings and precautions 5. Our material is not intended as a substitute for direct consultation with a qualified health professional. Aug 22, 2016 peramivir is effective against a variety of influenza a and b subtypes and has a lower halfmaximal inhibitory concentration compared to other nais in in vitro studies. These mutations are listed in the prescribing information package inserts for fdaapproved nais, including oseltamivir, zanamivir, and peramivir. Peramivir trade name rapivab is an antiviral drug developed by biocryst pharmaceuticals for. For laiv, which is administered intranasally, prepare the vaccine according to directions in the package insert. The us food and drug administration fda has approved a new neuraminidase inhibitor for acute uncomplicated influenza called peramivir rapivab, biocryst pharmaceuticals, which offers clinicians. Get emergency medical help if you have signs of an allergic reaction hives, difficult breathing, swelling in your face or throat or a severe skin reaction fever, sore throat, burning in your eyes, skin pain, red or purple skin rash that spreads and causes blistering and peeling. Peramivir side effects, dosage, interactions drugs. Full prescribing information 1 indications and usage fuzeonin combination with other antiretroviral agents is indicated for the treatment of hiv1 infection in treatmentexperienced patientswith evidence of hiv1 replication despite ongoing antiretroviral therapy. Peramivir injection in the treatment of acute influenza.
Outcomes and adverse effects with peramivir for the treatment. Arava leflunomide, tablets, for oral use prescribing. Please see full prescribing information for rapivab. Jun 21, 2018 crossresistance between zanamivir and oseltamivir or peramivir has been observed in neuraminidase inhibition assays and cell culture assays. Eight 73% patients tested positive for a strain of influenza a and 3 27% patients tested positive for influenza b. Medscape influenza dosing for rapivab peramivir, frequencybased adverse effects, comprehensive interactions. Standing orders for administering influenza vaccine to.
Summary of clinical trials of peramivir treatment in patients with influenza virus. Document peramivir synthland limited intermediates pdf. Rapivab peramivir injection important safety information indication. Rapivab peramivir dosing, indications, interactions, adverse effects. Peramivir is an intravenous neuraminidase inhibitor that is fdaapproved for the treatment of acute uncomplicated influenza in adults 18 years and older. Not known whether peramivir distributes into human milk, affects milk production, or has any effects on breastfed infants.
Highlights of prescribing information information for rapivab. Outcomes and adverse effects with peramivir for the. Nov 09, 2018 peramivir works by preventing an enzyme in the body from releasing virus from infected cells. As the leading independent provider of trustworthy medication information, we source our database directly from the fdas central repository of drug labels and package inserts under the structured product labeling standard. Highlights of prescribing information information for. Peramivir is an intravenous neuraminidase inhibitor. Abelcet amphotericin b lipid complex injection description abelcet is a sterile, pyrogenfree suspension for intravenous infusion. Tamiflu oseltamivir phosphate capsules and for oral. Peramivir is a novel cyclopentane neuraminidase inhibitor of influenza virus.
Influenza a virus hemagglutinin mutations associated with. The us food and drug administration fda has approved a new neuraminidase inhibitor for acute uncomplicated influenza called peramivir rapivab, biocryst pharmaceuticals, which. Additionally, peramivir has the ability to inhibit the replication of nine different types. Nai treatmentemergent h1 ha mutations were mapped onto the h1n1 ha1 trimeric crystal structure and most of them localized to the ha antigenic sites predicted to be important for antiinfluenza. Document peramivir intermediates pdf document synthland limited on.
Turn the entire unit bottle and oral dispenser upside down. The auc following a single 600 mg iv dose of peramivir was 80. Peramivir is used to treat influenza in adults and children who are at least 2 years old, who have had. Arava may cause fetal harm when administered to a pregnant woman. Highlights of prescribing information these highlights do not. Pdf safety and efficacy of peramivir for influenza treatment. A novel smallmolecule inhibitor of influenza a virus acts by suppressing pa endonuclease activity of the viral polymerase. Ten 91% patients demonstrated a larger volume of distribution, 11 100% patients demonstrated an increase in clearance, and 11 100% patients demonstrated a shorter half. It was approved by the food and drug administration in december 2014 for treatment of acute uncomplicated influenza in.
125 844 742 1288 1311 315 366 576 863 760 773 1004 1065 153 4 931 420 1388 202 1525 660 51 1244 831 1452 476 1278 358 1050 1220 570 1305 232 475